Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma extracellular vesicle modulate immune cell transcriptional responses following acute myocardial infarction.

iScience·2026
Same author

HDL Regulates TGFβ-Receptor Lipid Raft Partitioning, Restoring Contractile Features of Cholesterol-Loaded Vascular Smooth Muscle Cells.

JACC. Basic to translational science·2026
Same author

Endothelial thrombomodulin-Its role in trauma-induced coagulopathy.

Transfusion·2026
Same author

Trained Immunity and Cardiovascular Risk: An Immunological Perspective.

Immunological reviews·2026
Same author

Domain-Specific Progressive Channel Dropout: Single-Source Domain Generalization for Vessel Segmentation in X-ray Coronary Angiography.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Stabilisation of HIF signalling in the mouse epicardium extends embryonic potential and neonatal heart regeneration.

eLife·2025

Related Experiment Video

Updated: Jul 4, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Atherosclerosis regression.

Justin M S Lee1, Alistair C Lindsay, Ilias Kylintireas

  • 1Department of Cardiovascular Medicine, Level 5 John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.

Current Treatment Options in Cardiovascular Medicine
|June 28, 2008
PubMed
Summary
This summary is machine-generated.

Atherosclerosis plaque regression is now mappable using advanced imaging. This article reviews drugs that may help regress atherosclerotic plaques, offering new hope for managing this progressive disease.

Related Experiment Videos

Last Updated: Jul 4, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Area of Science:

  • Cardiovascular Medicine
  • Pathology
  • Pharmacology

Background:

  • Atherosclerosis involves low-density lipoprotein (LDL) deposition and oxidative modification in artery walls.
  • Macrophage foam cell formation and plaque progression lead to fibrous components and necrotic lipid cores.
  • Plaque size and composition, including lipid core, fibrous cap, and inflammation, dictate clinical risk.

Purpose of the Study:

  • To discuss drugs with potential or proven benefits in atherosclerosis regression.
  • To highlight advancements in imaging that enable mapping of plaque regression.

Main Methods:

  • Review of current literature on atherosclerosis pathogenesis and regression.
  • Discussion of pharmacological agents targeting key pathways in plaque development.
  • Emphasis on novel imaging techniques for quantifying plaque burden and composition.

Main Results:

  • Atherosclerosis, once thought to be relentlessly progressive, can now be mapped for regression using new imaging techniques.
  • Specific plaque characteristics (large lipid core, thin cap, inflammation) are linked to adverse clinical outcomes.
  • Several drugs show promise or have demonstrated efficacy in promoting atherosclerosis regression.

Conclusions:

  • Plaque regression is a viable therapeutic target in atherosclerosis management.
  • Pharmacological interventions combined with advanced imaging offer new strategies for combating cardiovascular disease.
  • Understanding plaque composition is crucial for predicting risk and guiding treatment decisions.